ROTOP Pharmaka

Executive Summary

ROTOP Pharmaka GmbH is a well-established German manufacturer and CDMO (Contract Development and Manufacturing Organization) specializing in radiopharmaceuticals for nuclear medicine. Founded in 1990 and based in Dresden, the company develops and produces diagnostic and therapeutic radiopharmaceuticals and cold kits under strict GMP standards, serving hospitals and clinics in Germany and internationally. Its comprehensive services cover the entire product lifecycle, including development, production, regulatory support, and logistics. With decades of experience and a focus on quality, ROTOP is positioned to benefit from the growing demand for nuclear medicine imaging and therapy, particularly in Europe. The company's private status and niche expertise in radiopharmaceutical CDMO make it a resilient player in a highly regulated market.

Upcoming Catalysts (preview)

• Q4 2026Capacity expansion for radiopharmaceutical production70% success
• Q2 2026New long-term CDMO contract with a major pharma partner50% success
• Q1 2027Regulatory approval for a new therapeutic radiopharmaceutical cold kit40% success